Moneycontrol PRO
Upcoming Webinar:Moneycontrol Pro in association with Quants League Sep'21 Edition brings to you to 5-Days Live Algorithmic Options Trading Virtual Conference. Register Now!

Hold Torrent Pharmaceuticals: target of Rs 3250: ICICI Direct

ICICI Direct recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 3250 in its research report dated July 28, 2021.

August 02, 2021 / 12:11 PM IST
  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Torrent Pharmaceuticals

Incorporated in 1959, Torrent has a strong presence in domestic and semi-regulated markets and a growing presence in regulated markets. Revenues – India including CRAMs (53%), Brazil (8%), US (16%) and Germany (13%). Torrent is the eighth largest domestic player and is ranked in top 10 for CVS, CNS, V&M, GI and anti-diabetes therapies in India


We change our rating from BUY to HOLD on the stock given recent run up We value Torrent at Rs 3250 i.e. 32x P/E on FY23E EPS


For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Aug 2, 2021 12:11 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark